EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diabetes mellitus is associated with altered Alzheimer's disease pathology

Diabetes mellitus ist mit veränderter Alzheimer-Krankheit-Pathologie assoziiert

Min Wu, Ying Luan, Xiaowen Xu, Xiaoxie Mao, Huiying Lin, Kun He, Qi Huang, Jie Zhang, Sheng Kuang, Yihui Guan, Alzheimer's Disease Neuroimaging Initiative, Health and Aging Brain Study (HABS‐HD) Team und 5 weitere

Alzheimer's & Dementia · 2026-11 · 22 (11)

DOI: 10.1002/alz.72002 ↗

Auf einen Blick

In 3 Beobachtungskohorten mit 2784 Teilnehmenden war DM mit geringerer globaler Aβ-Last, geringerer Tau-Akkumulation und langsamerem tau-bezogenem kognitivem Abbau assoziiert. Die Effekte waren bei kognitiver Beeinträchtigung ausgeprägter.

Fragestellung

Ist Diabetes mellitus mit Aβ- oder Tau-Akkumulation bei Alzheimer-Krankheit und mit kognitivem Verlauf assoziiert?

Methode

Analyse von 2784 Teilnehmenden aus 3 unabhängigen Beobachtungskohorten (CPAS, ADNI, HABS-HD) mit Aβ-PET, Tau-PET, Plasma-p-tau217 und longitudinalen Kognitionsdaten.

Ergebnisse

DM war in CPAS und ADNI mit niedrigerer globaler Aβ-Last und geringerer Tau-Akkumulation assoziiert. Die Assoziationen von Aβ und p-tau217 mit Tau-Akkumulation waren bei DM schwächer. In ADNI zeigte sich ein langsamerer tau-bezogener kognitiver Abbau.

Schlussfolgerung der Autor:innen

Die Autor:innen folgern, dass DM mit einer Abschwächung amyloid- und tau-bezogener Prozesse assoziiert ist, besonders bei kognitiv beeinträchtigten Teilnehmenden. Diabetesbezogene Mechanismen und deren Management könnten die AD-Pathologie modulieren.

Kernaussagen

  • DM: geringere globale Aβ-Last und geringere Tau-Akkumulation
  • Bei DM waren Aβ- und p-tau217-Assoziationen mit Tau schwächer
  • In ADNI war der tau-bezogene kognitive Abbau langsamer

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 10.11.2026. Verfasst von Min Wu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Brain, Diabetes Mellitus. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Natural Science Foundation of China, STI2030-Major Projects.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Diabetes mellitus (DM) is a major risk factor for dementia, yet it remains unclear whether DM accelerates cognitive decline through amyloid beta (Aβ) or tau accumulation in Alzheimer's disease (AD). METHODS In this study, we included 2784 participants from three independent observational cohorts: the Chinese Preclinical Alzheimer's Disease Study (CPAS), the Alzheimer's Disease Neuroimaging Initiative (ADNI), and Health and Aging Brain Study–Health Disparities (HABS‐HD). We examined the associations of DM with Aβ positron emission tomography (PET), tau PET, plasma phosphorylated tau (p‐tau)217, and longitudinal cognitive change. We also tested whether DM modified the associations of Aβ and plasma p‐tau217 with subsequent tau accumulation and explored the association of metformin use with tau accumulation. RESULTS We found that DM was associated with lower global Aβ burden and lower tau accumulation in CPAS and ADNI, in which cognitive impairment was more common than in HABS‐HD. The associations of Aβ and plasma p‐tau217 with tau accumulation were weaker among individuals with DM. In addition, DM was associated with reduced propagation of tau from early to later stage Braak regions. Longitudinal analyses in ADNI indicated that individuals with DM exhibited slower tau‐related cognitive decline. In exploratory analyses, metformin use among individuals with DM was associated with lower tau accumulation compared to individuals without DM. DISCUSSION These findings suggest that DM is associated with an attenuation of amyloid‐ and tau‐related processes, particularly in participants with cognitive impairment, and further suggest that diabetes‐related mechanisms and its management may modulate the progression of AD pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBrainDiabetes MellitusHumansFemaletau ProteinsPositron-Emission TomographyAmyloid beta-PeptidesMaleAgedCognitive DysfunctionAged, 80 and overLongitudinal Studies

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid betadementiadiabetes mellitustau accumulation

Substanzen

tau ProteinsAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Neurology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, China.
  • Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.
  • Department of Radiology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Center for Rehabilitation Medicine, Rehabilitation and Sports Medicine Research Institute of Zhejiang Province, Hangzhou, China.
  • Department of Rehabilitation Medicine, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, China.

ORCID-Profile: Fang Xie

Förderung

  • NIA NIH HHS
  • National Natural Science Foundation of China
  • STI2030-Major Projects
  • Huashan Hospital
  • Lingang Laboratory Grant
  • Key Research and Development Program of Zhejiang Province
  • Shanghai Municipal Health Commission
  • NIBIB NIH HHS

Zitieren

APA

Wu, M., Luan, Y., Xu, X., Mao, X., Lin, H., He, K., Huang, Q., Zhang, J., Kuang, S., Guan, Y., Alzheimer's Disease Neuroimaging Initiative, Health and Aging Brain Study (HABS‐HD) Team, O'Bryant, S., Li, B., Guo, Q., Xie, F., & Luo, B. (2026). Diabetes mellitus is associated with altered Alzheimer's disease pathology. Alzheimer's & Dementia, 22(11). https://doi.org/10.1002/alz.72002

Vancouver

Wu M, Luan Y, Xu X, Mao X, Lin H, He K, et al. Diabetes mellitus is associated with altered Alzheimer's disease pathology. Alzheimer's & Dementia. 2026;22(11). doi:10.1002/alz.72002

BibTeX
@article{Wu2026,
  author = {Wu, Min and Luan, Ying and Xu, Xiaowen and Mao, Xiaoxie and Lin, Huiying and He, Kun and Huang, Qi and Zhang, Jie and Kuang, Sheng and Guan, Yihui and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative and Health and Aging Brain Study (HABS‐HD) Team, Health and Aging Brain Study (HABS‐HD) Team and O'Bryant, Sid and Li, Binyin and Guo, Qihao and Xie, Fang and Luo, Benyan},
  title = {Diabetes mellitus is associated with altered Alzheimer's disease pathology},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {11},
  doi = {10.1002/alz.72002}
}
Kostenlos starten →